SUNPHARMA:NSE
Sun Pharmaceutical Industries Ltd
1Â 764,00Â INR
arrow_upward
+1,01%(+17,60) 1Â D
15. okt., 15:30:00 GMT+5:30 · INR
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for SUNPHARMA …
Ã…pne
1Â 736,00Â INR
Høy
1Â 778,00Â INR
Lav
1Â 734,10Â INR
Markedsverdi
4,23Â bill.
Snittvolum
1,58Â mill.
Volum
1,38Â mill.
Utbytte
0,91Â %
Kvartalsvis utbytte
4,00Â INR
Første dato etter utbytte
7. juli 2026
P/E-forhold
34,97
52 u høy
2Â 046,90Â INR
52Â u lav
1Â 583,70Â INR
EPS
50,44Â INR
Utestående aksjer
0,00
Antall ansatte
47k
Ã…pne
1Â 736,00Â INR
Høy
1Â 778,00Â INR
Lav
1Â 734,10Â INR
Markedsverdi
4,23Â bill.
Snittvolum
1,58Â mill.
Volum
1,38Â mill.
Utbytte
0,91Â %
Kvartalsvis utbytte
4,00Â INR
Første dato etter utbytte
7. juli 2026
P/E-forhold
34,97
52 u høy
2Â 046,90Â INR
52Â u lav
1Â 583,70Â INR
EPS
50,44Â INR
Utestående aksjer
0,00
Antall ansatte
47k
Nyhetssaker
Fra nettkilder og nyhetspartnere
ad-hoc-news.de
·
for 1 time siden
Analyst consensus puts Sun Pharma stock at INR 2,180.00
ad-hoc-news.de
·
for 5 timer siden
Sun Pharma approves INR 100.0 billion plan: Sun Pharma stock sits 13.79 percent below high
ad-hoc-news.de
·
for 2 døgn siden
Geojit raises target for Sun Pharma stock to INR 2,070.00
TipRanks
·
for 2 døgn siden
Sun Pharma Clears INR 10,000 Crore NCD Plan as Independent Director Resigns
Profil
Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. It manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients in more than 100 countries. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world.
Around 70% of Sun Pharma’s revenue is generated from international markets. The US and India are the largest markets, accounting for over 60% of the company's turnover. Manufacturing is across 43 locations in India, the US, Asia, Africa, Australia and Europe. The products cater to therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynaecology, respiratory, oncology, dental and nutritionals. Its active pharmaceutical products include baricitinib, brivaracetam, and dapaglifozin. Wikipedia
Om Sun Pharmaceutical Industries Ltd
Administrerende direktør-
Ansatte47k
Grunnlagt1983
HovedkontorGoregaon East, Mumbai, India
Sektor-
Nettstedsunpharma.com